|
ACETAZOLAMIDE POTENTIATES THE EFFECTS OF FOLIC ACID ANTAGONISTS
|
ANTAGONISTIC ANTIMALARIAL EFFECT
|
ANTAGONISTIC ANTIMALARIAL EFFECT
|
ANTAGONISTIC ANTIMALARIAL EFFECT
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
|
PHENYTOIN ANTIEPILEPTIC ACTIVITY IS ANTAGONISED BY THE DRUG BY REDUCING THE CONVULSIVE THRESHOLD, SO PHENYTOIN DOSE HAS TO BE INCREASED
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF HAEMATOLOGIC REACTIONS ON CONCURRENT USE
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
FOLIC ACID DEFICIENCY MAY PRECIPITATE WITH CONCURRENT USE
|